PHOSPHO2-KLHL23: A Drug Target / Disease Biomarker (G100526832)

Target Name: PHOSPHO2-KLHL23

NCBI ID: G100526832

PHOSPHO2-KLHL23

Other Name(s): PHOSPHO2-KLHL23 readthrough, transcript variant 2 | PHOSPHO2-KLHL23 variant 2 | PHOSPHO2-KLHL23 readthrough

PHOSPHO2-KLHL23: A Drug Target / Disease Biomarker

PHOSPHO2-KLHL23 is a protein that is expressed in various tissues throughout the body, including the brain, heart, kidneys, and liver. It is a key regulator of the blood-brain barrier, which is a specialized barrier that separates the brain from the surrounding blood vessels and lymphatic system. The blood-brain barrier is critical for the protection of the brain and nervous system from harmful substances, and it is also responsible for maintaining the integrity of the brain's delicate structure and function.

PHOSPHO2-KLHL23 is a protein that is known to be involved in the regulation of several different processes in the brain, including cell signaling, neurotransmitter release, and inflammation. It is thought to play a key role in the development and maintenance of the blood-brain barrier, as well as in the regulation of brain function and behavior.

One of the most promising aspects of PHOSPHO2-KLHL23 is its potential as a drug target. The blood-brain barrier is a difficult target to reach, because it is surrounded by the brain and is protected by several layers of specialized cells. However, recent studies have identified several potential drug targets that are involved in the regulation of the blood-brain barrier, including PHOSPHO2-KLHL23.

One potential drug target for PHOSPHO2-KLHL23 is the protein known as PDZ1. PDZ1 is a protein that is expressed in the brain and is involved in the regulation of many different processes, including cell signaling and neurotransmission. It is thought to play a key role in the development and maintenance of the blood-brain barrier, and it is also involved in the regulation of the brain's response to external stimuli.

Another potential drug target for PHOSPHO2-KLHL23 is the protein known as NF-kappa-B. NF-kappa-B is a protein that is involved in the regulation of many different processes in the body, including inflammation, cell signaling, and neurotransmission. It is thought to play a key role in the development and maintenance of the blood-brain barrier, and it is also involved in the regulation of the brain's response to external stimuli.

In conclusion, PHOSPHO2-KLHL23 is a protein that is involved in the regulation of several different processes in the brain, including cell signaling, neurotransmission, and inflammation. It is also thought to play a key role in the development and maintenance of the blood-brain barrier. As a result, PHOSPHO2-KLHL23 is a potential drug target for the treatment of a wide range of neurological and psychiatric disorders. Further research is needed to fully understand the role of PHOSPHO2-KLHL23 in the regulation of brain function and behavior, and to identify effective treatments.

Protein Name: PHOSPHO2-KLHL23 Readthrough

The "PHOSPHO2-KLHL23 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about PHOSPHO2-KLHL23 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets